Decreased thrombin activity levels in PAR KO following 24 hours following ischemia. حسب Efrat Shavit-Stein (3186678)

"…<p>(A) Total thrombin activity is significantly decreased in PAR1 KO compared to WT mice (t-test). …"

Pixel-wise trends in annual time series data of NDVI and Tmin during 1982 to 2015 (a) Sen’s slope of NDVI (b) p-values of NDVI, (c)significant trends (p<0.05) in average annual slo... حسب Jamal Hassan Ougahi (13513875)

الموضوعات:

Trends in the prevalence of dyslipidemia in patients with type 2 diabetes. حسب Amirhossein Yadegar (13922190)

الموضوعات:

Trends in the prevalence of dyslipidemia in patients with type 2 diabetes. حسب Amirhossein Yadegar (13922190)

الموضوعات:

Time series comparing trends at HSJ and control hospitals in the pre-intervention and intervention period. Significance test determine if trends differ between groups. حسب Eva Rydahl (6260771)

الموضوعات:

Analysis of Significantly Different Bacteria. حسب Xu Jia (187142)

Pre and pot COVID-19 total TB patients on follow-up trends over 8 months. حسب Beshir Bedru Nasir (8218863)

Adjusted Prevalence Ratios (aPR) of binge drinking for each fortnight during the pre-COVID19 (1^st Wave 2019–2020) and post-COVID19 (2^nd Wave 2021–22) period,... حسب Judit Rogés (19501037)

الموضوعات:

Descriptive statistics of outcomes at baseline, post-intervention, and follow-up and estimates of the linear mixed effects model for the outcomes. حسب Ana Beato (20489933)

الموضوعات:

Socio-demographic and medical characteristics of patients with liver cancer. حسب Ayana Ablayeva (22103708)

الموضوعات:

Data cleaning and preparation algorithm. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. حسب Ayana Ablayeva (22103708)

الموضوعات:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Regional and temporal burden of liver cancer in Kazakhstan (2014–2023). حسب Ayana Ablayeva (22103708)

الموضوعات: